Ethane

Ethane

SCHEMBL4640067

CC.CC(C)(C)OC(=O)c1ccc(Cl)cc1C(=O)O

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
TSHR P16473 2/20 0.49
TP53 P04637 1/20 0.49
CASP1 P29466 1/20 0.49
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
KDM4E B2RXH2 2/20 0.44
HSD17B10 Q99714 2/20 0.44
MYC P01106 2/20 0.43
NR4A1 P22736 1/20 0.43
SERPINE1 P05121 1/20 0.43
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
ABL1 P00519 1/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
SORT1 Q99523 1/20 0.41
GAA P10253 1/20 0.40
NPSR1 Q6W5P4 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27755305 0.98 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2TSHRTP53CASP1
5-Chlorosalicylic Acid SCHEMBL6514013 0.84 CA1 (0.67) ALDH1A1SMN1; SMN2TSHRTP53CASP1
Ethane SCHEMBL4640068 0.82 CSNK2A1 (0.49) ALDH1A1CA1CA2MEN1KMT2A
SCHEMBL7858859 0.81 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2TSHRTP53CNR1
SCHEMBL3843873 0.81 NR1H4 (0.54) ALDH1A1SMN1; SMN2TSHRCASP1KDM4E
Ethane SCHEMBL4640042 0.81 TSHR (0.41) ALDH1A1SMN1; SMN2TSHRTP53CASP1
SCHEMBL4640063 0.81 KMT2A (0.46) ALDH1A1SMN1; SMN2TSHRTP53CASP1
Ethane SCHEMBL4641157 0.81 GABRG2 (0.42) ALDH1A1GABRA1GABRG2GABRB3GABRA5
Ethane SCHEMBL4640227 0.81 KEAP1 (0.46) ALDH1A1SMN1; SMN2KDM4EHSD17B10GABRA1
Ethane SCHEMBL4639902 0.81 KDM4E (0.46) KDM4EHSD17B10MYCNR4A1SORT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1188739-B1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO LTD (JP) 2008-08-13 EP disclosed
US-6670497-B2 Dialkyl (at least one of which is a C4-8 tertiary alkyl) ester of an alkyl- or halo-substituted phthalic acid; used in an olefin polymerization catalyst TOHO TITANIUM CO., LTD. (JP) 2003-12-30 US disclosed
US-20030036594-A1 Phthalic diester derivatives and electron donors TOHO TITANIUM CO., LTD. (JP) 2003-02-20 US disclosed
EP-1188739-A1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO., LTD. (JP) 2002-03-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030036594-A1 Phthalic diester derivatives and electron donors HPD, ETFA, PPOX ALDH1A1 725/4885SMN1; SMN2 4567/4885TSHR 4817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.